| Emily Elizabeth Sladek, MD | |
|
354 Santa Fe Dr, Encinitas, CA 92024-5142 | |
| (760) 230-2251 | |
| (760) 230-2253 |
| Full Name | Emily Elizabeth Sladek |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Location | 354 Santa Fe Dr, Encinitas, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174850424 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | A114631 (California) | Primary |
| 207R00000X | Internal Medicine | A114631 (California) | Secondary |
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376646869 PECOS PAC ID: 3577476761 Enrollment ID: O20031112000695 |
News Archive
Clinical Data, Inc., today announced results from two Phase I studies of Stedivaze™ (apadenoson), which demonstrated that Stedivaze was safe and well tolerated in patients with asthma and chronic obstructive pulmonary disease (COPD). Stedivaze is a potent and highly selective agonist of the adenosine A2A receptor subtype in development as a pharmacologic stress agent for myocardial perfusion imaging (MPI).
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has received a grant from the National Institute of Health (NIH) to support the development of defensin-mimetic antimicrobial compounds for the treatment of malaria.
Spring weather signals the start of many outdoor activities as people of all ages eagerly embrace the change in weather. Paul Prinz, MD, orthopaedic surgeon at Gottlieb Memorial Hospital, part of Loyola University Health System says, "Broken bones and fractures occur year 'round but the change in seasons always creates an increase of patients in our offices."
An international research team led by Columbia University Medical Center successfully used mouse embryonic stem cells to replace diseased retinal cells and restore sight in a mouse model of retinitis pigmentosa. This strategy could potentially become a new treatment for retinitis pigmentosa, a leading cause of blindness that affects approximately one in 3,000 to 4,000 people, or 1.5 million people worldwide.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Elizabeth Sladek, MD Po Box 231189, Encinitas, CA 92023-1189 Ph: (760) 230-2251 | Emily Elizabeth Sladek, MD 354 Santa Fe Dr, Encinitas, CA 92024-5142 Ph: (760) 230-2251 |
News Archive
Clinical Data, Inc., today announced results from two Phase I studies of Stedivaze™ (apadenoson), which demonstrated that Stedivaze was safe and well tolerated in patients with asthma and chronic obstructive pulmonary disease (COPD). Stedivaze is a potent and highly selective agonist of the adenosine A2A receptor subtype in development as a pharmacologic stress agent for myocardial perfusion imaging (MPI).
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has received a grant from the National Institute of Health (NIH) to support the development of defensin-mimetic antimicrobial compounds for the treatment of malaria.
Spring weather signals the start of many outdoor activities as people of all ages eagerly embrace the change in weather. Paul Prinz, MD, orthopaedic surgeon at Gottlieb Memorial Hospital, part of Loyola University Health System says, "Broken bones and fractures occur year 'round but the change in seasons always creates an increase of patients in our offices."
An international research team led by Columbia University Medical Center successfully used mouse embryonic stem cells to replace diseased retinal cells and restore sight in a mouse model of retinitis pigmentosa. This strategy could potentially become a new treatment for retinitis pigmentosa, a leading cause of blindness that affects approximately one in 3,000 to 4,000 people, or 1.5 million people worldwide.
› Verified 2 days ago
Dr. Andy Huy Nguyen, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 354 Santa Fe Dr, Encinitas, CA 92024 Phone: 760-230-2251 | |
Chino S Mannikarottu, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 354 Santa Fe Dr, Encinitas, CA 92024 Phone: 760-230-2251 Fax: 760-230-2253 | |
Hui-shan Jenny Hsu, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 354 Santa Fe Dr, Encinitas, CA 92024 Phone: 760-230-2251 | |
Neema Froutan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 354 Santa Fe Dr, Encinitas, CA 92024 Phone: 760-230-2251 Fax: 760-230-2253 | |
Dr. Taiye A Gilles, M.D. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 310 Santa Fe Dr Ste 112, Encinitas, CA 92024 Phone: 760-642-7009 | |
Robert Matorin, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 354 Santa Fe Dr, Encinitas, CA 92024 Phone: 760-230-2251 Fax: 760-230-2253 |